12-Week Study of Plecanatide for CIC (The National CIC3 Study)
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm that the investigational medication, plecanatide, is
safe and effective in treating chronic idiopathic constipation.
Phase:
Phase 3
Details
Lead Sponsor:
Bausch Health Americas, Inc. Synergy Pharmaceuticals Inc.